5901 - 5910 of 7916 Results
Title
Year
-
RESTRICTEDTitle: Molecular Imaging and Updated Diagnostic Criteria in Lewy Body DementiasJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 17Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-017-0789-zBest OA location URL: https://europepmc.org/articles/pmc5873980?pdf=renderCitation Count: 28
-
OPENTitle: Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free AssaysJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 126Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/55361Best OA location URL: https://www.jove.com/pdf/55361/recombinant-synucleins-stimulate-protein-phosphatase-2a-catalyticCitation Count: 7
-
RESTRICTEDTitle: Alpha-synuclein oligomers: a new hopeJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 134Issue #: 6Start Page: 819End Page: 838Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-017-1755-1Best OA location URL: https://europepmc.org/articles/pmc5663814?pdf=renderCitation Count: 255
-
OPENTitle: Cholinergic activity and levodopa‐induced dyskinesia: a multitracer molecular imaging studyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 9Start Page: 632End Page: 639Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.438Best OA location URL: https://doi.org/10.1002/acn3.438Citation Count: 17
-
OPENTitle: LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson’s diseaseJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 26Issue #: 22Start Page: 4340End Page: 4351Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddx320Best OA location URL: https://academic.oup.com/hmg/article-pdf/26/22/4340/24339268/ddx320.pdfCitation Count: 83
-
OPENTitle: Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particlesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 8Start Page: e0181844End Page: e0181844Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0181844Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0181844&type=printableCitation Count: 28
-
OPENTitle: Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 44Issue #:Start Page: 13End Page: 17Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.08.006Best OA location URL: http://www.prd-journal.com/article/S1353802017302870/pdfCitation Count: 22
-
OPENTitle: Beliefs About Use of Complementary Health Approaches for Parkinson's DiseaseJournal Name: Holistic Nursing PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 31Issue #: 5Start Page: 290End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/hnp.0000000000000229Best OA location URL: https://europepmc.org/articles/pmc5664950?pdf=renderCitation Count: 0
-
OPENTitle: Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trialJournal Name: The LancetPublisher: Elsevier BVVol: 390Issue #: 10103Start Page: 1664End Page: 1675Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s0140-6736(17)31585-4Best OA location URL: https://europepmc.org/articles/pmc5831666?pdf=renderCitation Count: 603
-
OPENTitle: Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-017-07181-0Best OA location URL: https://www.nature.com/articles/s41598-017-07181-0.pdfCitation Count: 103